Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study
    Evans, Peter
    Sobieszczyk, Piotr
    Eisenhauer, Andrew C.
    Todoran, Thomas M.
    Kinlay, Scott
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2025, 105 (05) : 1214 - 1221
  • [2] Major Adverse Limb Events and Mortality After Peripheral Artery Revascularization in Hemodialysis Patients
    Lin, Ting-yun
    Hung, Szu-Chun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 552 - 552
  • [3] Risk of Major Adverse Limb Events and Benefits of Evolocumab in Patients With Peripheral Artery Disease by History of Prior Peripheral Revascularization
    Nault, Patrice
    Bonaca, Marc
    Giugliano, Robert P.
    Honarpour, Narimon
    Keech, Anthony C.
    Sever, Peter S.
    Pedersen, Terje R.
    Sabatine, Marc
    JOURNAL OF VASCULAR SURGERY, 2019, 69 (06) : E195 - E195
  • [4] Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization
    Desai, Urvi
    Kharat, Akshay
    Hess, Connie N.
    Milenthevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    Bonaca, Marc P.
    ANNALS OF VASCULAR SURGERY, 2021, 75 : 217 - 226
  • [5] Restenosis after endovascular revascularization in peripheral artery disease
    Malyar, Nasser M.
    Reinecke, Holger
    Freisinger, Eva
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2015, 44 (04) : 257 - 270
  • [6] Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease
    Anand, Sonia S.
    Caron, Francois
    Eikelboom, John W.
    Bosch, Jackie
    Dyal, Leanne
    Aboyans, Victor
    Abola, Maria Teresa
    Branch, Kelley R. H.
    Keltai, Katalin
    Bhatt, Deepak L.
    Verhamme, Peter
    Fox, Keith A. A.
    Cook-Bruns, Nancy
    Lanius, Vivian
    Connolly, Stuart J.
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (20) : 2306 - 2315
  • [7] Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization
    Hess, Connie N.
    Rogers, R. Kevin
    Wang, Tracy Y.
    Fu, Rao
    Gundrum, Jacob
    LaPointe, Nancy M. Allen
    Hiatt, William R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (09) : 999 - 1011
  • [8] Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease
    Berger, Ariel
    Simpson, Alex
    Bhagnani, Tarun
    Leeper, Nicholas J.
    Murphy, Brian
    Nordstrom, Beth
    Ting, Windsor
    Zhao, Qi
    Berger, Jeffrey S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (12): : 1893 - 1899
  • [9] Incidence and Costs of Major Atherothrombotic Vascular Events Among Patients With Peripheral Artery Disease After Revascularization
    Bonaca, Marc P.
    Hess, Connie N.
    Kharat, Akshay
    Desai, Urvi
    Milentijevic, Dejan
    Laliberte, Francois
    Zuckerman, Peter R.
    Benson, John
    Lefebvre, Patrick
    Hiatt, William R.
    CIRCULATION, 2020, 142
  • [10] Platelet Activity and Major Adverse Limb Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization
    Hernandez, Gustavo
    Rodriguez, Crystalann
    Lee, Angela
    Luttrell-Williams, Elliot
    Nardi, Michael A.
    Barrett, Tessa
    Suarez, Yajaria
    Jacobowitz, Glenn
    Maldonado, Thomas
    Hochman, Judith S.
    Rockman, Caron
    Berger, Jeffrey S.
    CIRCULATION, 2019, 140